Lineage Cell Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
10KSB
10QSB
144
25-NSE
3
3/A
4
4/A
424B1
424B3
424B5
425
5
5/A
8-A12B
8-A12G
8-K
8-K/A
ARS
AW
CERTNYS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFR14A
DEL AM
DFAN14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
REGDEX
RW
S-2
S-2/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-26-000908 | Mar 23, 2026 | — |
| 4 | 4 | 0001193125-26-104106 | Mar 12, 2026 | — |
| S-3 | S-3 | 0001193125-26-101168 | Mar 11, 2026 | — |
| 8-K | 8-K | 0001193125-26-101167 | Mar 11, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-101166 | Mar 11, 2026 | — |
| 4 | 4 | 0001193125-26-097185 | Mar 6, 2026 | Mar 5, 2026 |
| 4 | 4 | 0001193125-26-097184 | Mar 6, 2026 | Mar 5, 2026 |
| 4 | 4 | 0001193125-26-097181 | Mar 6, 2026 | Mar 5, 2026 |
| 10-K | 10-K | 0001193125-26-093992 | Mar 5, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-093948 | Mar 5, 2026 | — |
| 4 | 4 | 0001193125-26-052021 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | 4 | 0001193125-26-052020 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | 4 | 0001193125-25-327280 | Dec 19, 2025 | — |
| 4 | 4 | 0001193125-25-327279 | Dec 19, 2025 | — |
| 8-K | 8-K | 0001193125-25-302552 | Nov 28, 2025 | — |
| 8-K | 8-K | 0001193125-25-291979 | Nov 24, 2025 | Nov 20, 2025 |
| SCHEDULE 13D/A | — | 0000919574-25-007051 | Nov 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-276249 | Nov 12, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-276229 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-269599 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269534 | Nov 6, 2025 | — |
| SCHEDULE 13G | — | 0002042077-25-000004 | Sep 26, 2025 | — |
| 144 | — | 0001950047-25-007493 | Sep 24, 2025 | — |
| 144 | — | 0001950047-25-006959 | Sep 10, 2025 | — |
| 8-K | 8-K | 0000950170-25-111319 | Aug 26, 2025 | — |
| S-8 | S-8 | 0000950170-25-109396 | Aug 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-107333 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-107314 | Aug 12, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-003083 | Jul 17, 2025 | — |
| 4 | — | 0000919574-25-003973 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093470 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093469 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093468 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093467 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093466 | Jul 2, 2025 | Jul 1, 2025 |
| 8-K | 8-K | 0000950170-25-093007 | Jul 2, 2025 | Jun 26, 2025 |
| 8-K | 8-K | 0000950170-25-088738 | Jun 23, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-084916 | Jun 11, 2025 | — |
| 8-K | 8-K | 0000950170-25-083866 | Jun 9, 2025 | Jun 3, 2025 |
| 10-Q | 10-Q | 0000950170-25-070378 | May 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-070337 | May 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-061466 | May 1, 2025 | — |
| ARS | ARS | 0000950170-25-060148 | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-060123 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-060090 | Apr 29, 2025 | Jun 26, 2025 |
| SCHEDULE 13G | — | 0002052113-25-001535 | Apr 24, 2025 | — |
| 4 | 4 | 0000950170-25-038117 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-038116 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-038113 | Mar 12, 2025 | Mar 10, 2025 |
| 10-K | 10-K | 0000950170-25-036309 | Mar 10, 2025 | Dec 31, 2024 |